PreciControl Anti-HCV (cobas e 411/601/602) - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Roche Diagnostics Australia Pty Limited

classe:

Class 4

Fabriqué par:

Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany

Domaine thérapeutique:

41973 - Hepatitis C virus total antibody IVD, control

indications thérapeutiques:

PreciControl Anti-HCV is a ready-for-use control serum based on human serum both in the negative and positive concentration range. The controls are used for monitoring the accuracy of the Elecsys Anti-HCV and Elecsys Anti-HCV II immunoassays. PreciControl Anti-HCV is used for quality control of the Anti-HCV and Anti-HCV II immunoassays on the Elecsys and cobas e immunoassay analyzers.

Statut de autorisation:

A

Date de l'autorisation:

2013-09-13